Multicenter, prospective, single-arm clinical study to investigate the efficacy and safety of Zoladex (Goserelin acetate) 10.8 mg prior to surgery in Chinese premenopausal women with symptomatic uterine fibroids

Objectives To assess the effect and safety of Zoladex (Goserelin acetate) 10.8 mg in patients with uterine fibroids.Methods Fifty-three patients received Goserelin acetate 10.8 mg once and surgery was conducted at 12 weeks ± 7 days after drug injection. All assessments form baseline to week12/before...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Yanchun Liang, Ruyu Yang, Yajing Wei, Biqi Huang, Youguo Chen, Xinmei Zhang, Jilong Yao, Guoyun Wang, Hongluan Mao, Honghui Shi, Qing Yang, Junying Tang, Mei Ji, Keqin Hua, Shuzhong Yao
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Taylor & Francis Group 2024-12-01
Цуврал:	Gynecological Endocrinology
Нөхцлүүд:	Goserelin acetate uterine fibroids efficacy safety
Онлайн хандалт:	https://www.tandfonline.com/doi/10.1080/09513590.2024.2427190
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!